Ligand Pharmaceuticals | LGND - 부채에 대한이자 비용





부채에 대한이자 비용 변화 날짜
Agenus USD 16.02M 2.85M 2025-12
Amgen USD 657M 4M 2026-03
Anika Therapeutics 179.39M 556.84M 2026-03
Arrowhead Research USD 22.5M 811K 2025-12
Baxter International USD 58M 14M 2025-09
Bristol-Myers Squibb USD 411M 21M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Enviri Corporation USD 28.44M 1.74M 2025-12
Gilead Sciences USD 255M 1000K 2025-12
GlaxoSmithKline GBP 167M 21M 2026-03
Glaxosmithkline GBP 177.95M 6.05M 2025-09
Heron Therapeutics USD 600K 100K 2024-12
Insmed USD 20.6M 217K 2025-12
Intrexon USD 2K 5K 2024-06
Ionis Pharmaceuticals USD 17M 1000K 2026-03
Karyopharm Therapeutics USD 12.62M 1.24M 2025-12
Ligand Pharmaceuticals USD 910K 243K 2025-09
MacroGenics USD 3.34M 2.54M 2025-09
Merck USD 479M 67M 2026-03
Pacira USD 3.7M 193K 2026-03
Pfizer USD 711M 59M 2025-12
Rigel Pharmaceuticals USD 2.06M 31K 2024-09
Sangamo BioSciences 97.56M 11.39M 2025-06
Veracyte USD 2K 1000 2023-12